PHILADELPHIA, January 13, 2025: Morgan Lewis is representing Suvoda in a planned merger with Greenphire, a portfolio company of Thoma Bravo, aimed to create a more seamless clinical trial experience.
Suvoda is a global clinical trial technology company specializing in complex life-sustaining studies in therapeutic areas such as oncology, central nervous system (CNS), and rare diseases. Greenphire offers financial management and patient support tools for global clinical trials.
Partner Adam Prince and associates Lindsay Mozdziock and Scott Berman are advising Suvoda along with partner Joanne Soslow.